Martin Jansen

2.4k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Martin Jansen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Martin Jansen has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Martin Jansen's work include Lipoproteins and Cardiovascular Health (10 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Martin Jansen is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Martin Jansen collaborates with scholars based in Austria, Netherlands and Germany. Martin Jansen's co-authors include Billie M. Moats‐Staats, Judson J. Van Wyk, P. Kay Lund, James G. Simmons, A. Joseph D’Ercole, Mary Hynes, J. L. Van den Brande, Kurt Derfler, J.S. van der Hoeven and P.J.J. Van Munster and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Martin Jansen

37 papers receiving 1.8k citations

Hit Papers

Somatomedin-C/insulin-like growth factor-I and insulin-li... 1986 2026 1999 2012 1986 100 200 300 400

Peers

Martin Jansen
V. Shen United States
Simon W. Fox United Kingdom
Sean C. Harrington United States
Linda Crofts Australia
Yongmei Wang United States
U. Trechsel Switzerland
S. C. Manolagas United States
V. Shen United States
Martin Jansen
Citations per year, relative to Martin Jansen Martin Jansen (= 1×) peers V. Shen

Countries citing papers authored by Martin Jansen

Since Specialization
Citations

This map shows the geographic impact of Martin Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Jansen more than expected).

Fields of papers citing papers by Martin Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Jansen. The network helps show where Martin Jansen may publish in the future.

Co-authorship network of co-authors of Martin Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Jansen. A scholar is included among the top collaborators of Martin Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Jansen. Martin Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brinck, Jonas, Martin Jansen, Clément Blanchet, et al.. (2025). Structural, functional and biochemical characterisation of apolipoprotein(a)-containing low-density lipoproteins. Journal of Colloid and Interface Science. 701. 138760–138760.
2.
3.
Jansen, Martin, et al.. (2019). A mathematical model to estimate cholesterylester transfer protein (CETP) triglycerides flux in human plasma. BMC Systems Biology. 13(1). 12–12. 6 indexed citations
4.
Jansen, Martin, Brigitte König, Filiz Markfeld-Erol, et al.. (2018). Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study. Lipids in Health and Disease. 17(1). 49–49. 18 indexed citations
5.
Jansen, Martin, et al.. (2011). De herziene KNGF-richtlijn artrose heup-knie.. Data Archiving and Networked Services (DANS). 133(2). 275–80.
6.
Schmah, Oliver, J. W. Siebers, Stefan Zschiedrich, et al.. (2011). Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial). BMC Cancer. 11(1). 337–337. 29 indexed citations
7.
Cauza, Edmund, Martin Jansen, Ulrike Resch, et al.. (2004). Effects of LDL‐immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia. Journal of Clinical Apheresis. 19(4). 174–179. 6 indexed citations
8.
Sengoelge, Gürkan, Josef Kletzmayr, Martin Jansen, et al.. (2004). Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. Kidney International. 66(1). 295–302. 12 indexed citations
9.
Stummvoll, Georg, Martin Aringer, Martin Jansen, et al.. (2004). Immunoadsorption as a rescue therapy in systemic lupus erythematosus: considerations on safety and efficacy. Wiener klinische Wochenschrift. 116(21-22). 716–724. 21 indexed citations
10.
Rabitsch, Werner, Paul Knöbl, Erika Prinz, et al.. (2003). Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption. Bone Marrow Transplantation. 32(10). 1015–1019. 26 indexed citations
11.
Heinz, Gottfried, et al.. (2002). Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia. Metabolism. 51(8). 976–980. 14 indexed citations
12.
Dittrich, Elisabeth, Sabine Schmaldienst, Martin Langer, et al.. (2002). Immunoadsorption and Plasma Exchange in Pregnancy. Kidney & Blood Pressure Research. 25(4). 232–239. 28 indexed citations
13.
Schmaldienst, Sabine, Martin Jansen, Ursula Hollenstein, et al.. (2002). Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis. American Journal of Kidney Diseases. 39(2). 415–418. 16 indexed citations
14.
Banyai, S., et al.. (2001). Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment. Atherosclerosis. 159(2). 513–519. 35 indexed citations
15.
Schmaldienst, Sabine, S. Banyai, Thomas M. Stulnig, et al.. (2000). Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia. Atherosclerosis. 151(2). 493–499. 44 indexed citations
16.
Kostner, Karam, S. Banyai, Martin Jansen, et al.. (1999). Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivo. Clinica Chimica Acta. 288(1-2). 21–30. 11 indexed citations
17.
Kostner, Karam, Martin Jansen, Gerald Maurer, & Kurt Derfler. (1997). LDL‐apheresis significantly reduces urinary apo(a) excretion. European Journal of Clinical Investigation. 27(1). 93–95. 18 indexed citations
18.
Schut, Frits, et al.. (1995). Substrate uptake and utilization by a marine ultramicrobacterium. Microbiology. 141(2). 351–361. 34 indexed citations
19.
Steeg, P. F. Ter, J.S. van der Hoeven, M. H. De Jong, P.J.J. Van Munster, & Martin Jansen. (1988). Modelling the Gingival Pocket by Enrichment of Subgingival Microflora in Human Serum in Chemostats. Microbial Ecology in Health and Disease. 1(2). 73–84. 53 indexed citations
20.
Steeg, P. F. Ter, J.S. van der Hoeven, M. H. De Jong, P.J.J. Van Munster, & Martin Jansen. (1987). Enrichment of subgingival microflora on human serum leading to accumulation of Bacteroides species, Peptostreptococci and Fusobacteria. Antonie van Leeuwenhoek. 53(4). 261–271. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026